Pfizer's COVID-19 vaccine gets nod in South Korea from first of three expert panels

The first of three expert panels in South Korea reviewing a COVID-19 vaccine developed by Pfizer Inc and BioNTech gave its recommendation on Tuesday for the government to approve the vaccine.